Thyroidectomy stimulates glucagon-like peptide-1 secretion and attenuates hepatic steatosis in high-fat fed rats

Jong Yeon Kang1, Mikyung Kim1, Yuna Kang2

  • 1Department of Biochemistry, School of Medicine, Keimyung University, Daegu, Republic of Korea.

Insights

Surgery-induced hypothyroidism in rats reduced body weight and appetite. This metabolic shift was linked to increased GLP-1, suggesting a potential therapeutic pathway for obesity and fatty liver disease.

Area of Science:

  • Metabolic research
  • Endocrinology
  • Obesity research

Background:

  • Thyroid hormones (THs) influence metabolism, but their precise role in obesity treatment remains unclear.
  • Understanding the mechanisms of TH action is crucial for developing effective obesity interventions.

Purpose of the Study:

  • To investigate the metabolic effects of surgically induced hypothyroidism in high-fat diet (HFD) fed rats.
  • To elucidate the detailed mechanisms underlying these metabolic changes.

Main Methods:

  • Surgical thyroidectomy (Thx) was performed on HFD-fed Sprague Dawley (SD) rats.
  • Evaluated body weight, food and water intake, insulin response, lipid profiles, and gene expression.
  • Measured circulating and intestinal glucagon-like peptide-1 (GLP-1) levels.

Main Results:

  • Hypothyroid rats exhibited decreased body weight, food, and water intake.
  • Total cholesterol, HDL, and LDL increased, while serum and hepatic triglycerides decreased.
  • Circulating and small intestine GLP-1 expression significantly increased.
  • Hepatic expression of lipogenic genes decreased, while beta-catenin and glutamine synthetase were upregulated.
  • Gluconeogenic genes (G6P, PCK) expression in the liver was reduced.

Conclusions:

  • Surgery-induced hypothyroidism in HFD rats leads to reduced appetite and body weight.
  • Increased GLP-1 appears to play a role in mediating these effects, potentially reducing hepatic steatosis.
  • These findings suggest hypothyroidism's impact on metabolic regulation and offer insights into potential therapeutic strategies for obesity.

Related Concept Videos

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.1K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.8K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
7.3K